Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesPractice Management'Financial toxicity' screening for cancer care needs improvementScreening for "financial toxicity" in cancer care could use improvement in the U.S., according to a new review.CTOpportunistic chest CT helps predict low bone mineral densityMolecular ImagingNew guidance issued on PET/CT imaging in breast cancerDigital X-RayIMV: Hospital-based diagnostic x-ray volumes continue to declineSponsor ContentWe care about what you think.